ArticleJournal of pain research2025
Risk of Opioid Use Disorder in Surgical Patients with Medicaid and Associations with Prescription Opioid Dose and Duration.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Buprenorphine Microinduction Treatment in Tri-Diagnosis Patients with Opioid Use Disorder and Chronic Non-Cancerous Pain.Current pain and headache reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Introduction: Opioids are commonly used to treat postoperative pain. Risk of opioid use disorder (OUD) in opioid-naive Medicaid patients undergoing surgery is not well studied. We investigated the incidence of OUD after opioid prescription in opioid-naïve patients undergoing surgery and estimated the association between reducing prescription duration and/or dose on risk of OUD. Methods: We analyzed data from Medicaid T-MSIS Analytic Files from 25 states of opioid-naïve adults who underwent surgery and received perioperative opioid prescription from 2016 to 2019. Associations between reducing opioid prescription on risk of OUD were estimated using a non-parametric, doubly robust estimator. Results: This study included 178,133 people who underwent a non-cesarean section surgery and 164,936 who underwent a cesarean section. OUD incidence, excluding cesarean section, was 0.84% and 1.47% at 1 and 2 years postoperatively, and OUD incidence after cesarean section was 0.77% and 1.44% at 1 and 2 years. For non-cesarean section patients, reducing opioid prescription duration by 20% as well as dose and duration by 20% were associated with a relative risk reduction of OUD at 2 years of 15% (95% CI 11%, 18%) and 27% (95% CI 23%, 30%), respectively. For cesarean section, the same reductions were associated with a relative risk reduction of OUD at 2 years of 18% (95% CI 14%, 22%) and 26% (95% CI 22%, 30%). Reducing dose alone did not significantly reduce risk of OUD. Discussion: In opioid-naïve Medicaid patients undergoing surgery, reduction in opioid prescription duration and daily dose was estimated to reduce risk of incident OUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.